2. Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta- analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health 2019;7:e448–e460.

3. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011;9:81.

4. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009;80:634–639.

5. Wallis RS, Hafner R. Advancing host-directed therapy for tuberculosis. Nat Rev Immunol 2015;15:255–263.

6. Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 2018;17:35–56.

7. Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med 2014;6:263ra159.

8. Horakova O, Kroupova P, Bardova K, et al. Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Sci Rep 2019;9:6156.

9. He L. Metformin and Systemic Metabolism. Trends Pharmacol Sci 2020;41:868–881.

10. Restrepo BI. Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients. Tuberculosis (Edinb) 2016;101S:S69–S72.

11. Pan SW, Yen YF, Kou YR, et al. The risk of TB in patients with type 2 diabetes initiating metformin vs sulfonylurea treatment. Chest 2018;153:1347–1357.

12. Zhang M, He JQ. Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis. Eur J Clin Pharmacol 2020;76:149–159.

13. Degner NR, Wang JY, Golub JE, Karakousis PC. Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment. Clin Infect Dis 2018;66:198–205.

14. Jeong D, Kang HY, Kim J, et al. Cohort profile: Korean Tuberculosis and Post-Tuberculosis Cohort Constructed by linking the Korean National Tuberculosis Surveillance System and National Health Information Database. J Prev Med Public Health 2022;55:253–262.

16. Austin PC. Double propensity-score adjustment: a solution to design bias or bias due to incomplete matching. Stat Methods Med Res 2017;26:201–222.

17. Reed GW, Choi H, Lee SY, et al. Impact of diabetes and smoking on mortality in tuberculosis. PLoS One 2013;8:e58044.

18. World Health Organization and International Union Against Tuberculosis and Lung Disease. Collaborative framework for care and control of tuberculosis and diabetes [Internet] Geneva: World Health Organization, c2011. [cited 2023 July 15]. Available from: https://apps.who.int/iris/handle/10665/44698. 19. Baker C, Retzik-Stahr C, Singh V, Plomondon R, Anderson V, Rasouli N. Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab 2021;12:2042018820980225.

20. Vashisht R, Brahmachari SK. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med 2015;13:83.

21. Li WD, Li NP, Song DD, Rong JJ, Qian AM, Li XQ. Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK/mTOR/autophagy pathway. Int J Mol Med 2017;39:1262–1268.

22. Stek C, Allwood B, Walker NF, Wilkinson RJ, Lynen L, Meintjes G. The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy. Front Microbiol 2018;9:2603.

23. Elkington PT, Ugarte-Gil CA, Friedland JS. Matrix metalloproteinases in tuberculosis. Eur Respir J 2011;38:456–464.

24. Heinz P, Wendel-Garcia PD, Held U. Impact of the matching algorithm on the treatment effect estimate: a neutral comparison study. Biom J 2024;66:2100292.

25. Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 2014;370:233–244.

26. Yen YF, Chuang PH, Yen MY, et al. Association of body mass index with tuberculosis mortality: a population-based follow-up study. Medicine (Baltimore) 2016;95:e2300.

27. Bhargava A, Chatterjee M, Jain Y, et al. Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PLoS One 2013;8:e77979.

28. Hanrahan CF, Golub JE, Mohapi L, et al. Body mass index and risk of tuberculosis and death. AIDS 2010;24:1501–1508.